We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $38.6B
1-Year Est. Return 45.89%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.57%
5 Year Est. Return
+159.2%
10 Year Est. Return
+646.93%
AUM
$73B
AUM Growth
+$28B
Cap. Flow
+$23.7B
Cap. Flow %
32.43%
Top 10 Hldgs %
49.61%
Holding
1,873
New
618
Increased
371
Reduced
476
Closed
336

Sector Composition

Rank Sector Weight
1 Technology 1.19%
2 Consumer Discretionary 0.76%
3 Financials 0.36%
4 Communication Services 0.35%
5 Healthcare 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIFR
1776
XPLR Infrastructure LP
XIFR
$1.12B
-7,220
Closed -$526K
QVCGA
1777
CALL
DELISTED
QVC Group Inc Series A
QVCGA
-400
Closed -$235K
FFAI
1778
CALL
Faraday Future Intelligent Electric
FFAI
$12.7M
-1
Closed -$17.3M
FFAI
1779
Faraday Future Intelligent Electric
FFAI
$12.7M
0
-$538K
NKLA
1780
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
-5,417
Closed -$2.26M
ZUO
1781
DELISTED
Zuora, Inc.
ZUO
-389
Closed -$6.22K
SUM
1782
CALL
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-336,627
Closed -$9.28M
SUM
1783
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-112
Closed -$3K
PETQ
1784
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-13,512
Closed -$476K
PETQ
1785
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-25,000
Closed -$882K
ME
1786
CALL
DELISTED
23andMe Holding Co
ME
-4,645
Closed -$945K
ME
1787
DELISTED
23andMe Holding Co
ME
-169
Closed -$34K
VIEW
1788
DELISTED
View, Inc. Class A Common Stock
VIEW
-35
Closed -$17.2K
TRHC
1789
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-5,023
Closed -$231K
TRHC
1790
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-64,200
Closed -$2.96M
SDC
1791
CALL
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-193,800
Closed -$2M
RETA
1792
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-20,000
Closed -$2M
RETA
1793
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-566
Closed -$56K
WWE
1794
DELISTED
World Wrestling Entertainment
WWE
-5,136
Closed -$292K
WWE
1795
PUT
DELISTED
World Wrestling Entertainment
WWE
-200
Closed -$11K
NUVA
1796
CALL
DELISTED
NuVasive, Inc.
NUVA
-16,700
Closed -$1.09M
NUVA
1797
DELISTED
NuVasive, Inc.
NUVA
-871
Closed -$57K
PDCE
1798
CALL
DELISTED
PDC Energy, Inc.
PDCE
-39,000
Closed -$1.34M
CYXT
1799
CALL
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
-20,000
Closed -$199K
RUTH
1800
CALL
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-21,000
Closed -$521K

Similar funds

Parallax Volatility Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, Parallax Volatility Advisers held 1,873 positions worth $73B, up 62% from $44.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Parallax Volatility Advisers deployed $23.7B of net new capital in Q2 2021, opening 618 new positions and adding to 371 existing holdings. Its largest new stake was Microsoft: 1,082,293 shares worth $293M.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $173M trimmed.

  • Parallax Volatility Advisers's largest Q2 2021 buy was Microsoft: 1,082,293 shares worth $293M.
  • Parallax Volatility Advisers added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2021, an estimated $77.8M increase.
  • Parallax Volatility Advisers's biggest Q2 2021 reduction was NVIDIA, cutting an estimated $173M.
  • Parallax Volatility Advisers fully exited Sea Limited in Q2 2021, selling an estimated $160M.
  • Parallax Volatility Advisers's ten largest holdings make up 50% of its $73B portfolio in Q2 2021.
  • Parallax Volatility Advisers opened 618 new positions and closed 336 in Q2 2021.
  • Parallax Volatility Advisers's portfolio value rose 62% quarter-over-quarter to $73B.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.